Literature DB >> 18467629

Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel.

Jin O-Uchi1, Hiroyuki Sasaki, Satoshi Morimoto, Yoichiro Kusakari, Hitomi Shinji, Toru Obata, Kenichi Hongo, Kimiaki Komukai, Satoshi Kurihara.   

Abstract

We examined the effect of alpha(1)-adrenoceptor subtype-specific stimulation on L-type Ca2+ current (I(Ca)) and elucidated the subtype-specific intracellular mechanisms for the regulation of L-type Ca2+ channels in isolated rat ventricular myocytes. We confirmed the protein expression of alpha(1A)- and alpha(1B)-adrenoceptor subtypes at the transverse tubules (T-tubules) and found that simultaneous stimulation of these 2 receptor subtypes by nonsubtype selective agonist, phenylephrine, showed 2 opposite effects on I(Ca) (transient decrease followed by sustained increase). However, selective alpha(1A)-adrenoceptor stimulation (> or =0.1 micromol/L A61603) only potentiated I(Ca), and selective alpha(1B)-adrenoceptor stimulation (10 mumol/L phenylephrine with 2 micromol/L WB4101) only decreased I(Ca). The positive effect by alpha(1A)-adrenoceptor stimulation was blocked by the inhibition of phospholipase C (PLC), protein kinase C (PKC), or Ca2+/calmodulin-dependent protein kinase II (CaMKII). The negative effect by alpha(1B)-adrenoceptor stimulation disappeared after the treatment of pertussis toxin or by the prepulse depolarization, but was not attributable to the inhibition of cAMP-dependent pathway. The translocation of PKCdelta and epsilon to the T-tubules was observed only after alpha(1A)-adrenoceptor stimulation, but not after alpha(1B)-adrenoceptor stimulation. Immunoprecipitation analysis revealed that alpha(1A)-adrenoceptor was associated with G(q/11), but alpha(1B)-adrenoceptor interacted with one of the pertussis toxin-sensitive G proteins, G(o). These findings demonstrated that the interactions of alpha(1)-adrenoceptor subtypes with different G proteins elicit the formation of separate signaling cascades, which produce the opposite effects on I(Ca). The coupling of alpha(1A)-adrenoceptor with G(q/11)-PLC-PKC-CaMKII pathway potentiates I(Ca). In contrast, alpha(1B)-adrenoceptor interacts with G(o), of which the betagamma-complex might directly inhibit the channel activity at T-tubules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467629     DOI: 10.1161/CIRCRESAHA.107.167734

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  32 in total

1.  Involvement of protein kinase C and protein kinase A in the enhancement of L-type calcium current by GABAB receptor activation in neonatal hippocampus.

Authors:  J G Bray; M Mynlieff
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  Adrenergic signaling controls RGK-dependent trafficking of cardiac voltage-gated L-type Ca2+ channels through PKD1.

Authors:  Bong Sook Jhun; Jin O-Uchi; Coeli M B Lopes; Zheng Gen Jin; Weiye Wang; Chang Hoon Ha; Jinjing Zhao; Ji Young Kim; Chelsea Wong; Robert T Dirksen
Journal:  Circ Res       Date:  2011-11-10       Impact factor: 17.367

3.  Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma.

Authors:  Takanori Hama; Yuki Yuza; Toshihito Suda; Yoshimichi Saito; Chihiro Norizoe; Takakuni Kato; Hiroshi Moriyama; Mitsuyoshi Urashima
Journal:  Clin Exp Metastasis       Date:  2011-09-28       Impact factor: 5.150

4.  Isoform-specific dynamic translocation of PKC by α1-adrenoceptor stimulation in live cells.

Authors:  Jin O-Uchi; Jaime Sorenson; Bong Sook Jhun; Jyotsna Mishra; Stephen Hurst; Kaleef Williams; Shey-Shing Sheu; Coeli M B Lopes
Journal:  Biochem Biophys Res Commun       Date:  2015-08-12       Impact factor: 3.575

5.  Protein kinase D activation induces mitochondrial fragmentation and dysfunction in cardiomyocytes.

Authors:  Bong Sook Jhun; Jin O-Uchi; Stephanie M Adaniya; Thomas J Mancini; Jessica L Cao; Michelle E King; Amy K Landi; Hanley Ma; Milla Shin; Donqin Yang; Xiaole Xu; Yisang Yoon; Gaurav Choudhary; Richard T Clements; Ulrike Mende; Shey-Shing Sheu
Journal:  J Physiol       Date:  2018-01-25       Impact factor: 5.182

6.  Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter.

Authors:  Jin O-Uchi; Bong Sook Jhun; Shangcheng Xu; Stephen Hurst; Anna Raffaello; Xiaoyun Liu; Bing Yi; Huiliang Zhang; Polina Gross; Jyotsna Mishra; Alina Ainbinder; Sarah Kettlewell; Godfrey L Smith; Robert T Dirksen; Wang Wang; Rosario Rizzuto; Shey-Shing Sheu
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

7.  Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Authors:  Emily A Oestreich; Sundeep Malik; Sanjeewa A Goonasekera; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.

Authors:  Norimichi Koitabashi; Takeshi Aiba; Geoffrey G Hesketh; Janelle Rowell; Manling Zhang; Eiki Takimoto; Gordon F Tomaselli; David A Kass
Journal:  J Mol Cell Cardiol       Date:  2009-12-01       Impact factor: 5.000

9.  Noradrenaline stimulates cell proliferation by suppressing potassium channels via G(i/o) -protein-coupled α(1B) -adrenoceptors in human osteoblasts.

Authors:  D Kodama; A Togari
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  Protein kinase A-dependent modulation of Ca2+ sensitivity in cardiac and fast skeletal muscles after reconstitution with cardiac troponin.

Authors:  Douchi Matsuba; Takako Terui; Jin O-Uchi; Hiroyuki Tanaka; Takao Ojima; Iwao Ohtsuki; Shin'ichi Ishiwata; Satoshi Kurihara; Norio Fukuda
Journal:  J Gen Physiol       Date:  2009-05-11       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.